Merging alcohol giants threaten global health

Jeffrey Collin, Sarah E. Hill, Katherine E Smith

    Research output: Contribution to journalEditorial

    12 Citations (Scopus)

    Abstract

    The world’s two largest beer manufacturers, Anheuser-Busch InBev (AB InBev) and SABMiller, have agreed in principle to merge. AB InBev, the Belgium based producer of global brands such as Budweiser, Corona, and Stella Artois will acquire London based SABMiller, brewer of Peroni, Miller, and Grolsch. At £70bn (€100bn; $106bn) this would be the third largest deal in corporate history, establishing a dominant position in the global beer market. Its completion depends on navigating the regulatory demands of competition policy in multiple jurisdictions. Yet the real importance of the deal is what it symbolises for the future of the global alcohol industry. Here we focus on its implications for the growing epidemic of alcohol related harm across low and middle income countries.
    LanguageEnglish
    Article numberh6087
    Number of pages2
    JournalBMJ
    Volume351
    DOIs
    Publication statusPublished - 17 Nov 2015

    Fingerprint

    alcohol
    Alcohols
    competition policy
    Belgium
    health
    jurisdiction
    producer
    Industry
    History
    income
    industry
    market
    history
    Global Health

    Keywords

    • alcohol industry
    • company merger
    • public health
    • policy
    • alcohol
    • drinks industry
    • tobacco

    Cite this

    Collin, Jeffrey ; Hill, Sarah E. ; Smith, Katherine E. / Merging alcohol giants threaten global health. In: BMJ . 2015 ; Vol. 351.
    @article{067a38f621af491d96db467fdfe1cbfe,
    title = "Merging alcohol giants threaten global health",
    abstract = "The world’s two largest beer manufacturers, Anheuser-Busch InBev (AB InBev) and SABMiller, have agreed in principle to merge. AB InBev, the Belgium based producer of global brands such as Budweiser, Corona, and Stella Artois will acquire London based SABMiller, brewer of Peroni, Miller, and Grolsch. At £70bn (€100bn; $106bn) this would be the third largest deal in corporate history, establishing a dominant position in the global beer market. Its completion depends on navigating the regulatory demands of competition policy in multiple jurisdictions. Yet the real importance of the deal is what it symbolises for the future of the global alcohol industry. Here we focus on its implications for the growing epidemic of alcohol related harm across low and middle income countries.",
    keywords = "alcohol industry, company merger, public health, policy, alcohol, drinks industry, tobacco",
    author = "Jeffrey Collin and Hill, {Sarah E.} and Smith, {Katherine E}",
    year = "2015",
    month = "11",
    day = "17",
    doi = "10.1136/bmj.h6087",
    language = "English",
    volume = "351",
    journal = "BMJ",
    issn = "0959-8138",

    }

    Merging alcohol giants threaten global health. / Collin, Jeffrey; Hill, Sarah E.; Smith, Katherine E.

    In: BMJ , Vol. 351, h6087, 17.11.2015.

    Research output: Contribution to journalEditorial

    TY - JOUR

    T1 - Merging alcohol giants threaten global health

    AU - Collin, Jeffrey

    AU - Hill, Sarah E.

    AU - Smith, Katherine E

    PY - 2015/11/17

    Y1 - 2015/11/17

    N2 - The world’s two largest beer manufacturers, Anheuser-Busch InBev (AB InBev) and SABMiller, have agreed in principle to merge. AB InBev, the Belgium based producer of global brands such as Budweiser, Corona, and Stella Artois will acquire London based SABMiller, brewer of Peroni, Miller, and Grolsch. At £70bn (€100bn; $106bn) this would be the third largest deal in corporate history, establishing a dominant position in the global beer market. Its completion depends on navigating the regulatory demands of competition policy in multiple jurisdictions. Yet the real importance of the deal is what it symbolises for the future of the global alcohol industry. Here we focus on its implications for the growing epidemic of alcohol related harm across low and middle income countries.

    AB - The world’s two largest beer manufacturers, Anheuser-Busch InBev (AB InBev) and SABMiller, have agreed in principle to merge. AB InBev, the Belgium based producer of global brands such as Budweiser, Corona, and Stella Artois will acquire London based SABMiller, brewer of Peroni, Miller, and Grolsch. At £70bn (€100bn; $106bn) this would be the third largest deal in corporate history, establishing a dominant position in the global beer market. Its completion depends on navigating the regulatory demands of competition policy in multiple jurisdictions. Yet the real importance of the deal is what it symbolises for the future of the global alcohol industry. Here we focus on its implications for the growing epidemic of alcohol related harm across low and middle income countries.

    KW - alcohol industry

    KW - company merger

    KW - public health

    KW - policy

    KW - alcohol

    KW - drinks industry

    KW - tobacco

    U2 - 10.1136/bmj.h6087

    DO - 10.1136/bmj.h6087

    M3 - Editorial

    VL - 351

    JO - BMJ

    T2 - BMJ

    JF - BMJ

    SN - 0959-8138

    M1 - h6087

    ER -